13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Better mood and mental clarity: Supports overall nervous system health by aiding in the proper functioning of nerve cells and signaling pathways, which can help you feel more focused and alert throughout the day
Saline can cause precipitation of the peptide
lipotropic therapy is not an FDA-approved drug for treating, curing, or preventing any disease